Quantcast
Last updated on April 17, 2014 at 9:25 EDT

Latest Connective tissue diseases Stories

2011-11-02 05:00:00

ABBOTT PARK, Ill., Nov. 2, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) scientists and independent researchers will highlight the latest research findings on HUMIRA® (adalimumab) at this year's American College of Rheumatology (ACR) Annual Scientific Meeting, scheduled for November 5-9 in Chicago. The presentations include data on rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), ankylosing spondylitis (AS) and spondyloarthritis (SpA), as well as health...

2011-10-28 12:01:30

A simpler system would make it easier for clinicians to treat kidney problems in lupus patients     The current classification system for the kidney disorder called lupus nephritis is too detailed     Physicians would benefit from a simpler classification system when they treat kidney problems in patients with lupus     Lupus nephritis affects approximately 3 out of every 10,000 people, and it can be serious and lead to kidney failure The...

2011-10-27 11:19:00

$1 Million for Lupus Research NEW YORK, Oct. 27, 2011 /PRNewswire-USNewswire/ -- A milestone in lupus research was met this weekend! On Saturday, October 22(nd) the Alliance for Lupus Research (ALR) held its 8th annual New York City Walk with Us to Cure Lupus. The beautiful weather at Battery Park was matched by the enthusiasm of the nearly 3000 walkers in attendance to walk for the cure. The walkers were joined by NYC master of ceremonies, My9 news anchor Brenda Blackmon, ALR Chairman...

2011-10-27 06:25:44

(Ivanhoe Newswire) -- Women with lupus are 50 times more likely to have a heart attack; and all lupus patients are eight times more likely to develop premature coronary heart disease than the general population. Statins, a class of drug used to lower cholesterol, have been shown to reduce arthrosclerosis progression in adults, but have not been investigated in a pediatric lupus population. Atherosclerosis is a build-up of plaque in the arterial wall which can lead to heart attack and...

2011-10-25 15:30:00

HAYWARD, Calif., Oct. 25, 2011 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has completed enrollment in the Phase 2b PEARL-SC study. PEARL-SC (A randomized, double-blind Phase 2b study to evaluate the efficacy, safety, and tolerability of blisibimod administration in subjects with systemic lupus erythematosus) is examining the therapeutic benefit of...

2011-10-24 20:00:00

HAYWARD, Calif., Oct. 24, 2011 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it will release its third quarter 2011 financial report and provide an update on its development programs after market close on Tuesday, November 1, 2011. Anthera will host a conference call at 5 pm Eastern Time in conjunction with the release. Conference Call Access:...

2011-10-18 06:30:00

ATLANTA, Oct. 18, 2011 /PRNewswire/ -- Lupus Foundation of America, Georgia Chapter will host its annual Night of Hope Gala on Saturday, November 12, 2011 at Mason Murer. This charity event generates funding for the only statewide lupus programs, advocacy and lupus research. The evening will include auctions, dinner, cocktails, entertainment and an introduction to the 2012 Faces of Hope. This year's Gala promises to be a true celebration. With the recent FDA approval of Benlysta, the...

2011-10-17 11:00:00

$8 Million Grant Launches Search for Fundamental Causes Driving to a Cure NEW YORK, Oct. 17, 2011, /PRNewswire-USNewswire/ -- The Lupus Research Institute (LRI) launched a major international initiative aimed at attracting the highest level scientists to conduct pioneering research to discover the fundamental root causes of lupus, explore the potential for a cure, and transform the field of lupus research. LRI president Margaret Dowd announced the new Distinguished Innovators program amid...

2011-10-13 12:03:00

Grant Promotes Physical Activity through Arthritis Foundation's Certified Exercise Programs in Southern California LOS ANGELES, Oct. 13, 2011 /PRNewswire-USNewswire/ -- The Arthritis Foundation, Pacific Region, has received a grant from the Anthem Blue Cross Foundation to expand its patient education and evidence-based exercise classes that will reduce the pain and disability of arthritis for thousands of southern California residents. The Arthritis Foundation's Life Improvement...

2011-10-12 10:35:00

PORTLAND, Ore., Oct. 12, 2011 /PRNewswire-USNewswire/ -- If you have psoriasis or a family history of psoriasis and you are experiencing joint pain and swelling, you could have psoriatic arthritis, a serious disease that may lead to joint destruction and disability. New research from the National Psoriasis Foundation reveals that nearly one in four people with psoriasis--the most common autoimmune disease in the country, affecting as many as 7.5 million Americans--may have undiagnosed...